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Objectives. To investigate whether sacral surface therapeutic electrical stimulation (SSTES) initiated during the early postoperative
period would be eﬀective towards early recovery of postprostatectomy urinary continence. Methods.At o t a lo f3 5c o n s e c u t i v e
patients who underwent radical prostatectomy by a single surgeon were enrolled in this study. Twenty early patients began pelvic
ﬂoor muscle exercise (PME). Fifteen subsequent patients received SSTES postoperatively with no instruction for PME provided.
Immediate urinary function just after catheter removal was evaluated with frequency-volume chart and 24-hour pad test. Results.
There were no diﬀerences between the SSTES and PME groups in maximum voided volume capacity (MVV) and urine loss ratio
(ULR) on the ﬁrst day after removal of urethral catheter. However, on day 3 MVV was signiﬁcantly larger and ULR was also
signiﬁcantly lower in the SSTES group. Conclusions. SSTES treatment is feasible and appears to be eﬀective for early recovery of
urinary continence after radical prostatectomy.
1.Introduction
Urinary incontinence and sexual dysfunction are repre-
sentative long-term complications of radical prostatectomy.
During several months after radical prostatectomy, urinary
incontinence develops in most patients, signiﬁcantly lower-
ing their quality of life (QOL). One year after the surgery,
the incidence of urinary incontinence, the ratio of patients
who require pads, and the ratio of those who experience
urinary incontinence, even if only slightly, reach 5%–15%,
33%, and 66%, respectively [1, 2]. The main mechanism of
postprostatectomy incontinence is considered to be damage
of the sphincter muscle caused upon separation of the
prostate and urethra. It has been clariﬁed in recent years
that preservation of the neurovascular bundle could be
involved in the recovery of urinary continence [3], and
thus a neurogenic mechanism for the sphincter muscle was
indicated. In addition, detrusor overactivity can develop as a
consequence of traction of the bladder. It has been reported
that urinary incontinence related to detrusor overactivity
occurs in 40% and detrusor overactivity incontinence occurs
in 13% of patients after radical prostatectomy [4]. To
improve the postoperative urinary continence, we should
consider not only urinary sphincter muscle damage but also
bladder-related factors.
Pelvic ﬂoor exercise (PME) has been widely performed
after radical prostatectomy with the aim of the prevention
and treatment of urinary incontinence. The eﬀectiveness of
the PME depends on its instruction method, and recent
reports have suggested that the eﬀectiveness would become
higher by using the preoperative biofeedback method [5].
Neuromodulation, using electrical or magnetic stim-
ulation, was developed for urgency incontinence as well
as stress incontinence [6]. These methods were used to
treatpostprostatectomyincontinence(PPI)[7–10].Acertain
eﬀect was observed in these studies, while these studies were
applied only for patients with urinary incontinence. We
developed sacral surface therapeutic electrical stimulation2 Advances in Urology
(SSTES) as a therapy for urinary incontinence using neu-
romodulation [11]. In this therapy, skin surface electrodes
are applied on the sacral surface to provide stimulation,
making the treatment very easy to perform. It has been
shown that SSTES has not only an inhibitory eﬀect on
detrusor overactivity but also an eﬀerent stimulant eﬀect
to the pudendal nerve [11]. It is thus expected that SSTES
initiated in an early postoperative period would be eﬀective
for early recovery of postoperative urinary continence.
2.MaterialsandMethods
The study population consisted of 40 consecutive patients
who underwent retropubic radical prostatectomy for newly-
diagnosed, clinicallylocalized prostate cancer from Novem-
ber 2004 to November 2006. All of the operations were
performed by a single surgeon (Y.A.) and technical modiﬁ-
cations were not made except smaller skin incision during
the study period. This surgeon experienced more than 500
radical retropubic prostatectomy procedures over 20 years.
The patients with prolonged indwelling urethral catheter
due to anastomotic leakage (two cases) and who required
reinsertion of the urethral catheter because of transient
dysuria (one case) were excluded from the study, since the
longdurationoftheindwellingurethralcathetermightaﬀect
theimmediatecontinencepostcatheterremoval.Thepatients
who could not complete the frequency volume chart (one
case) and withdrew his consent for the use of the SSTES (one
case) were also excluded. Thus, a total of 35 patients were
enrolled in the study. Among them, 20 early patients (from
November 2004 to December 2005) received instruction for
the PME and began the exercise one day before the surgery
and continued for 1 week or longer. Fifteen subsequent
patients (from January 2006 to November 2006) received
SSTES,whichwasstartedatpostoperativeday1withnoPME
instruction provided. None of the patients were prescribed
anticholinergic drugs during this study. For SSTES, the
stimulator was specially designed for this purpose (Nodoka,
Lintec Co. Ltd., Tokyo, Japan) (Figure 1), and a pair of
speciallydesigned plate electrodes with a contact surface 4-
cm × 9-cm (width × height; Electrode type A, Lintec,
Tokyo, Japan) (Figure 1) were placed symmetrically on the
skin surface over the second through fourth posterior sacral
foramens. Pulses of 30-Hz frequency at 200-µs pulse width
andmaximumoutputof80Vwer eusedfor15minutestwic e
a day for 1 week. Intensity was controlled by each patient
below the pain threshold. The urethral catheter was removed
on day 5 or 6 postsurgery. Immediate urinary function just
after catheter removal was evaluated with a daily frequency-
volume chart and 24-hour pad test. The urine loss ratio [12]
was deﬁned as the weight of urine loss in the pad divided
by the daily urine volume, that is, micturition volume
plus incontinence volume. The maximum voided volume
(MVV) was deﬁned as largest voided volume during single
micturition from daily frequency-volume chart. The Ethics
Committee of the Tohoku University School of Medicine
approved this study and informed consent was obtained
from all of the patients. Statistical software (JMP Statistical
Discovery Software, SAS Institute, Cary, NC, USA) was used
for all analyses. Tested groups were compared by unpaired
Student’s t-test; P-values <. 05 were considered statistically
signiﬁcant.
3. Results
Table 1 presents the patient demographics and pathological
characteristics. There were no signiﬁcant diﬀerences in any
of the baseline clinical or pathologic parameters between the
two groups: age, PSA, tumor stage, biopsy Gleason score, or
degree of nerve preservation. No diﬀerences were observed
in any of the postoperative parameters: operative time,
estimated blood loss, prostate weight, pathological stage,
or positive surgical margin status. During hospitalization,
each group received the scheduled PME or SSTES treatment,
respectively, under the instruction of the nursing staﬀ.
One patient in the SSTES group, who experienced sinus
tachycardia and discomfort during electrical stimulation,
with a fever of 38 degrees centigrade and expressed a
desire to stop electrical stimulation, was excluded from the
analysis.
On the ﬁrst day after removal of the urethral catheter,
there were no signiﬁcant diﬀerences between the SSTES and
PME groups in maximum voided volume (229.3 ± 79.2ml
(mean ± standard deviation) versus 217.4 ± 99.5ml, resp.;
P = .35)orurinelossratio(13.8±19.9%versus14.5±23.7%,
resp.; P = .46). However, the maximum voided volume
and urine loss ratio were rapidly improved in the SSTES
group (Figures 2 and 3). On the third day after removal of
the urethral catheter, the maximum bladder capacity was
signiﬁcantly larger in the SSTES group than in the PME
group (315.0 ± 59.9ml versus 268.1 ± 94.6ml, resp.; P<
.05). Urine loss ratio was also signiﬁcantly lower in the
SSTES group (1.18 ± 1.36% versus 10.32 ± 22.7%, P<. 05).
During the study period, there were no signiﬁcant adverse
eﬀects observed, except for the one case described above. No
patients showed the symptom of diﬃculty on urination. No
patients complained dysuria or urinary retention during the
hospital stay.
4. Discussion
In the literature, urinary incontinence is one cause of lower-
ing the quality of life for patients following radical prostate-
ctomy. Many eﬀorts, including neuromodulation, have been
made to achieve early urinary continence. Yokoyama et al.
reported that extracorporeal magnetic stimulation improved
continence in 60% of patients with PPI [9, 10]. On the
otherhand,tworandomizedcontrolstudiesfailedtoshowan
additional eﬀect of neuromodulation for PPI compared with
PME alone [7, 8]. In these studies, electrical stimulation was
applied with an anal surface electrode and was initiated after
urethral catheter removal. Furthermore, in all of the studies
noted above, neuromodulatory stimulation was applied in
patients with existing urinary incontinence. It is well known
that early rehabilitation has an advantage for early andAdvances in Urology 3
(a) (b)
Figure 1: Portable electrical stimulator (Nodoka, Lintec Co. Ltd., Tokyo, Japan) and a pair of the specially-designed electrodes. A pair of
electrodes was placed symmetrically on the skin surface over the second through fourth posterior sacral foramens.
Table 1: The demographic and clinical characteristics of the patient population.
PFE (n = 20) SS- TES (n = 15) P∗
Age (year) 63.1 ± 6.4 61.4 ± 6.6. 4 6
PSA 10.7 ± 9.1 9.8 ± 6.6 .72
Clinical stage
T1 70% 80%
T2 15% 13%
T3 15% 7% .72 c
Biopsy Gleason sum
65 % 7 %
7 85% 86%
85 % 7 %
95 % 0 % . 8 4 c
Nerve sparing
No nerve sparing 10% 13%
Unilateral 50% 33%
Bilateral 40% 53% .62 c
Operation time 221 ±66 226 ±71 .85
Blood loss 1170 ±721 838 ±360 .11
Prostate weight 59.7 ±30.14 5 .1 ±12.8. 0 9
Pathological stage
pT2 80% 77%
pT3 20% 23% .74 c
Positive margin 20% 13% .60 c
c: Chi-square test.
∗Unpaired t-test unless otherwise noted.
satisfactory functional recovery in nonurological ﬁelds, such
as orthopedics [13], cardiac surgery [14], neurosurgery [15],
and spinal cord trauma [16]. PPI occurs due to surgical
damage of the urethral sphincter, pelvic ﬂoor muscle, and
bladder. From this perspective, we generated the idea of
initiating electrical stimulation on the ﬁrst day after radical
prostatectomy. As a result of this early electrical rehabilita-
tion, signiﬁcant eﬀects on early recovery of continence and
maximum voided volume were observed. To our knowledge,
this is the ﬁrst report on the possible rehabilitative role of
neuromoduration for PPI.
The present study showed the possible utility of SSTES
for early recovery of urinary function following radi-
cal prostatectomy. We previously shown that postcatheter
removal incontinence is signiﬁcantly related to postoperative
urinary function after radical prostatectomy [17]. Therefore,
it is expected that minimizing the postcatheter removal
incontinence could ultimately aﬀect the postoperative uri-
nary quality of life. In this study, on the ﬁrst day after
catheter removal, there were no diﬀerences in maximum
voided volume or urine loss ratio between the SSTES and
PME groups. On the other hand, on the third day after4 Advances in Urology
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Figure 2: Maximum voided volume at day 1, 2, and 3 after removal
of the urethral catheter. Error bars represent SEs. ∗P<. 05.
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Figure 3: Percentage of urine loss ratio at day 1, 2, and 3 after
removal of the urethral catheter. The urine loss ratio was deﬁned
as the weight of urine loss in the pad divided by the daily urine
volume. Error bars represent SEs. ∗P<. 05.
catheter removal, the maximum voided volume and urine
loss ratio rapidly improved with SSTES.
It has been reported that SSTES exhibits not only an
inhibitory eﬀect on detrusor overactivity but also an eﬀerent
stimulant eﬀect via the pudendal nerve [11]. The eﬀect
may be partly due to decreasing urgency with electrical
stimulation [18]. Pelliccioni and scarpino reported the
external anal sphincter response with S3 surface electrical
stimulation [19]. Indeed, we macroscopically observed that
contraction of the pelvic ﬂoor muscle including the urethral
sphincter and levator muscle was synchronized with SSTES
during open radical prostatectomy (data not shown). The
eﬀerent eﬀect on the pudendal nerve, which is equivalent
to the eﬀect of pelvic ﬂoor muscle exercise, and the aﬀerent
inhibitory eﬀect can be expected for injured pelvic ﬂoor
muscle and detrusor overactivity that develops after radical
prostatectomy. Based on the results of this study, SSTES
appears to have an early rehabilitative role on postprostate-
ctomy urinary function.
We acknowledge several limitations in this pilot study.
First, our study had relatively few patients. Second, although
there was no statistical diﬀerence, the prostate volume
and blood loss were smaller in the SSTES group, which
may have inﬂuenced the results. Third, the study was not
performed in a randomized fashion but as a historical
control study. However, all operations were performed by a
single,well-experiencedsurgeonandtechnicalmodiﬁcations
were not made during the study that might minimize the
intraoperator’s bias, such as a learning eﬀect. Fourth, one of
the drawbacks of the neuromodulatory approach is the short
carry-over eﬀect. It is unknown whether 1-week of electrical
stimulation could aﬀect the recovery of urinary function for
1 month or longer after surgery. Indeed, it was diﬃcult to
accuratelyevaluateurinelossratiousingthe24-hourpadtest
on an outpatient basis. In the present pilot study, the optimal
duration of SSTES remains to be elucidated. Nevertheless,
the results show the possible rehabilitative role of SSTES in
the early phase of recovery of urinary function following
radical prostatectomy
A multi-institutional, randomized controlled study with
a large number of subjects is now on going.
5. Conclusion
We investigated the rehabilitative role of SSTES for recovery
of urinary function following radical prostatectomy. This
treatment is feasible and appears to be eﬀective for early
recovery of urinary continence after surgery. A randomized
controlled trial with a large study population is warranted to
conﬁrm its eﬀectiveness.
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